133 related articles for article (PubMed ID: 31711926)
21. Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11.
Yang ML; Uhrig J; Vu K; Singapuri A; Dennis M; Gelli A; Thompson GR
Antimicrob Agents Chemother; 2015 Dec; 60(3):1202-7. PubMed ID: 26643330
[TBL] [Abstract][Full Text] [Related]
22. Correlation of antifungal susceptibility and sequence types within Cryptococcus neoformans VNI from HIV patients, and ERG11 gene polymorphism.
Bive BZ; Sacheli R; Mudogo CN; Zakayi PK; Bontems S; Lelo GM; Hayette MP
J Mycol Med; 2023 Nov; 33(4):101428. PubMed ID: 37651769
[TBL] [Abstract][Full Text] [Related]
23. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD
Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
[TBL] [Abstract][Full Text] [Related]
26. Emerging Cryptococcus gattii species complex infections in Guangxi, southern China.
Huang C; Tsui CKM; Chen M; Pan K; Li X; Wang L; Chen M; Zheng Y; Zheng D; Chen X; Jiang L; Wei L; Liao W; Cao C
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008493. PubMed ID: 32845884
[TBL] [Abstract][Full Text] [Related]
27. Comparison of
Oliveira LSS; Pinto LM; de Medeiros MAP; Toffaletti DL; Tenor JL; Barros TF; Neves RP; Neto RGL; Milan EP; Padovan ACB; Rocha WPDS; Perfect JR; Chaves GM
Front Cell Infect Microbiol; 2021; 11():642658. PubMed ID: 34277464
[TBL] [Abstract][Full Text] [Related]
28. First report of cryptococcosis due to Cryptococcus gattii sensu stricto VGI in an Ivorian HIV negative patient.
Bellet V; Kassi FK; Krasteva D; Roger F; Drakulovski P; Mossou C; Kouakou GA; Doumbia A; Delaporte E; Menan H; Bertout S
J Mycol Med; 2021 Jun; 31(2):101113. PubMed ID: 33540367
[TBL] [Abstract][Full Text] [Related]
29. Clinical and microbiological characteristics of Cryptococcus gattii isolated from 7 hospitals in China.
Jin L; Cao JR; Xue XY; Wu H; Wang LF; Guo L; Shen DX
BMC Microbiol; 2020 Mar; 20(1):73. PubMed ID: 32228457
[TBL] [Abstract][Full Text] [Related]
30. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
31. Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains.
Xue X; Zang X; Xiao M; Wang L; Wu H; Ma X; Wu N; Deng H; Zhou M; Pan L; Shen D; Wang J
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35641230
[TBL] [Abstract][Full Text] [Related]
32. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
33. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.
Stone NR; Rhodes J; Fisher MC; Mfinanga S; Kivuyo S; Rugemalila J; Segal ES; Needleman L; Molloy SF; Kwon-Chung J; Harrison TS; Hope W; Berman J; Bicanic T
J Clin Invest; 2019 Mar; 129(3):999-1014. PubMed ID: 30688656
[TBL] [Abstract][Full Text] [Related]
34. Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex.
Sá NP; Lima CM; Lino CI; Barbeira PJS; Baltazar LM; Santos DA; Oliveira RB; Mylonakis E; Fuchs BB; Johann S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533240
[TBL] [Abstract][Full Text] [Related]
35. Implication of efflux pumps and
Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
[No Abstract] [Full Text] [Related]
36. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
37. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.
Sanguinetti M; Posteraro B; La Sorda M; Torelli R; Fiori B; Santangelo R; Delogu G; Fadda G
Infect Immun; 2006 Feb; 74(2):1352-9. PubMed ID: 16428784
[TBL] [Abstract][Full Text] [Related]
38. Determination of the minimum inhibitory concentration of Cryptococcus neoformans and Cryptococcus gattii against fluconazole by flow cytometry.
Morales BP; Junior IN; Trilles L; Bertho AL; Oliveira Rde V; Nishikawa MM; Elias Mdos S; Wanke B; Lazéra Mdos S
Med Mycol; 2014 Jan; 52(1):90-8. PubMed ID: 23808405
[TBL] [Abstract][Full Text] [Related]
39. Successful Isavuconazole Salvage Therapy for a Cryptococcus deuterogattii (AFLP6/VGII) Disseminated Infection in a European Immunocompetent Patient.
Cuetara MS; Jusdado Ruiz-Capillas JJ; Nuñez-Valentin MP; Rodríguez Garcia E; Garcia-Benayas E; Rojo-Amigo R; Rodriguez-Gallego JC; Hagen F; Colom MF
Mycopathologia; 2021 Aug; 186(4):507-518. PubMed ID: 34115285
[TBL] [Abstract][Full Text] [Related]
40. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
